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1 K.J. and Y.C.L. contributed equally to this work.A-kinase anchoring proteins (AKAPs) are known to compartmentalise protein kinase(s) to discrete
cellular locations. Here we show that silencing of AKAP 18 a or c expression results in decreased or
increased glucose-stimulated insulin secretion in INS-1E cells. Glucose stimulates AKAP 18 a and
inhibits AKAP 18 c mRNA expressions while palmitate markedly reduces AKAP 18 a expression.
Human growth hormone (GH) stimulates AKAP 18 a expression and attenuates palmitate-induced
suppression of AKAP 18 a mRNA level. The roles of AKAP 18 a and c in mediating insulin release
are consistent with their respective regulations by glucose.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A-kinase anchoring protein (AKAP) 18, also known as AKAP 7/
15, is a member of a large family of functionally related proteins
(AKAPs) [1,2]. AKAPs were originally discovered based on their
association with regulatory subunit II (R II) of protein kinase A
(PKA) [3]. Multivalent AKAPs interacting with RI and RII subunits
of PKA and complexing with protein kinase C (PKC) and calcium/
calmodulin-dependent phosphatase (PP2B), have also been de-
scribed and characterized [4]. AKAPs contain conserved PKA bind-
ing domains and unique targeting sequences belonging to each
individual AKAP that direct the PKA–AKAP complex to a particular
sub-cellular location [5]. Four AKAP 18 transcript variants, a, b, c,
and d have been identiﬁed. AKAP 18 a/b and AKAP 18 c/d mRNAs
differ in the truncation of the 50 end, while all AKAP 18 isoforms
have an identical C-terminal 64 amino-acids core [6,7]. Fraser
et al. originally cloned AKAP 18 a and showed that when it was
over-expressed in RINm5F cells the insulin release mediated by
glucagon-like peptide 1 (GLP-1) was signiﬁcantly higher than cells
transfected with mutant AKAP 18 a [1]. GLP-1 is a glucose-depen-
dent insulinotropic hormone which stimulates insulin release via
pathways dependent or independent of cAMP and protein kinase
A (PKA) [8]. Activation of PKA has positive effect on L-type calciumchemical Societies. Published by E
spitalet, Københavns Biocen-
. Fax: +45 3545 6088.channels and ATP-sensitive potassium channels, which play key
roles in insulin release [8]. Various AKAPs have been detected in
pancreatic tissues including man [5], and AKAP18 expression in
INS-1 cells has been documented [9] (Supplementary data). Here,
we have explored the effects of AKAP 18 isoform-speciﬁc tran-
scripts silencing on insulin release and their regulations in INS-
1E cells.2. Materials and methods
2.1. Small interference RNAi
siRNA duplexes for AKAP 18 and the negative siRNA control
were from Ambion, and an additional siRNA duplex for AKAP 18
was from Integrated DNA Technology (IDT). The sequence
details of siRNA are (50-30, sense/antisense): AKAP 18 a: GAAUGGC-
GAUGGCAGUGAUtt/AUCACUGCCAUCGCCAUUCcg; AKAP 18 c:
CAGCUGGAAUUAAAGUCUUtt/AAGACUUUAAUUCCAGCUGta. The
IDT RNAi duplex (RNS.RNAI.N001001801.3.1) is: AGCUCCUUU-
CUAAUCUUGGCCUGGGUC/CCCAGGCCAAGAUUAGAAAGGAGCT.
2.2. siRNA transfection of INS-1E cells
INS-1E cells were kindly provided by Drs. Pierre Maechler and
Claes B Wollheim (University of Geneva, Switzerland) and grown
in RPMI 1640 containing 11 mM glucose with 10% FCS (foetal calf
serum, Invitrogen). 4  105 INS-1E cells were seeded in each welllsevier B.V. All rights reserved.
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ciﬁc siRNA in 400 ll Opti-Mem (Invitrogen) containing 2 ll dhar-
mafect 4 (Dharmacon). Four hours later, 600 ll of RPMI 1640
was added to each well.
2.3. Stimulation of transfected cells
Twenty-four hours after transfection, medium was changed to
RPMI 1640 with 0.5% FCS; 48 h after transfection, cells were
incubated for 2 h in RPMI 1640 with 0.5% FCS and 3 mM glucose,
and followed by 30 min in Ca5 buffer (125 mM NaCl, 5.9 mM KCl,
1.28 mM CaCl2, 1.2 mM MgCl2, 25 mM HEPES, 0.1% BSA, RIA
grade) containing 3 mM glucose. The stimulation was then car-
ried out for 30 min in Ca5 buffer with either 3 or 20 mM glucose
in the presence or absence of 5 lM forskolin (Fsk, Sigma). Med-
ium was collected for insulin ELISA (Mercodia, Sweden). The
number of live cells in all wells was estimated using resazurin
(Sigma) [10]. Brieﬂy, 10% of a 110 mg/l solution was added to
the cells for 1 h and the plate read at 534/585 nm. The insulin
secretion was then normalized with respect to the number of
live cells.Fig. 1. Comparative AKAP 18 mRNA variants expression in INS-1E cells and rat islets b
(n = 6) and rat islets (n = 3) cultured in RPMI 1640 were used for PCR. Quantitative PCR da
(top left) while AKAP 18 a and c have comparable expressions in rat islets (top right). Th
that ampliﬁes both AKAP 18 a/b transcripts as well as gel-electrophoresis analysis of t
domain of the Akap 18 variants.2.4. Palmitate exposure, human GH treatment and glucose stimulation
of INS-1E cells
INS-1E cells (8  105) were cultured in RPMI 1640 medium as
previously described [11]. One day before the experiment, medium
was changed to RPMI 1640 containing 0.5% FCS. On the day of
experiment, RPMI with 0.5% FCS, 5.5 or 11 mM glucose and
2.75 mg/ml fatty-acid free BSA was added to the cells with or with-
out 250 lM palmitate and with or without 0.5 lg/ml GH for 24 h.
Glucose alone stimulation experiments were for 24 h with glucose
concentrations at 5.5, 16.7, and 22.2 mM.
2.5. RNA isolation and quantitative RT-PCR
Total RNA from INS-1E cells was isolated using Trizol (Invitro-
gen) and 0.75 lg of RNA was reversed-transcribed using iScript
(Bio-Rad Laboratories AB, Sweden). Quantitative PCR (qPCR) was
performed using the LightCycler (Roche, Germany) with FastStart
SYBR Green Plus PCR mix (Roche), and relative expression was
determined by the calibration-curve method as previously de-
scribed [11] using porphobilinogen deaminase (PD) as endogenousy quantitative RT-PCR. cDNAs generated from total RNAs isolated from INS1E cells
ta show AKAP 18 a is the predominantly expressed transcript variant in INS1 E cells
e AKAP 18 variant-sequence-speciﬁc PCR primers, location of primer-pair (217-bp)
he ampliﬁed products are shown (A–E) (bottom). RII is the conserved PKA binding
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(details Fig. 1A–E) and primers for PD were synthesized by Sig-
ma-Genosys Ltd. (Cambridge, UK). The primers for PD were ATT-
CGGGGAAACCTCAACAC (sense) and CCCACAGCATACATGCATT
(antisense).
2.6. Statistical analyses
Data are presented as average ± S.E.M. Statistical analysis was
carried out using Student’s t-test when comparing two groups
and one-way ANOVA when comparing multiple groups. Differ-
ences were considered signiﬁcant at P < 0.05.
3. Results and discussion
3.1. All AKAP 18 transcript variants are expressed in INS-1E cells and
rat islets
We ﬁrst examined AKAP 18 transcript variant expression in
INS-1E cells and rat islets. qPCR demonstrated all four AKAP 18
transcripts in INS-1E cells and rat islets, with highest level of
expression for AKAP 18 a in INS-1E cells, and AKAP a and c show-
ing comparable levels of expression in islets (Fig. 1, top). Sequence
analysis of PCR products coupled with homology search (Blastx,
NCBI) revealed that the PCR-generated 217-bp fragment (Fig. 1B,
lower band) from rat islets has 98% translated identity with mouseFig. 2. Suppressions of AKAP 18 transcript variants and glucose-induced insulin secretion
siRNA duplex (20 nM) targeting the AKAP 18 a (A) and AKAP 18 c (B), as well as negative
were stimulated with either 3 mM or 20 mM glucose with or without forskolin (Fsk, 5 lM
48 h are as shown: (A and B). Results are means ± S.E.M. of three independent experiment
(three separate experiments) and (D) (two independent experiments), respectively. AKA
***P < 0.003, Student’s t-test.AKAP 18 a isoform (NP_061217), and 73% with human AKAP 18 a
(NP_004833) while the 286-bp fragment (Fig. 1B, top band) from
rat islets has 73% translated identity with human AKAP 18 b iso-
form (NP_619539) (Supplementary table). The 69-bp difference
between the two ampliﬁed fragments (217-bp vs. 286-bp) corre-
sponding to a 23-amino acid residue difference, was in agreement
with the ﬁndings between AKAP 18 a and b transcript variants in
man by Trotter et al. [7]. Sequence analysis of PCR ampliﬁed frag-
ments using AKAP 18-variants-speciﬁc primers coupled with
Blastn homology searches showed that AKAP 18 a (206-bp)
(Fig. 1A) was 100% identical with mouse AKAP 18 a (AF047716),
AKAP 18 c (151-bp) (Fig. 1D) was 96% identical with rat AKAP 18
d (AY350741), and AKAP 18 d (219-bp) (Fig. 1E) was 100% identical
with rat AKAP 18 d (AY350741) (Blastn data not shown).
3.2. AKAP 18 a/c silencing increases/decreases insulin secretion
We next assessed the effects of AKAP 18 a and c silencing on
insulin release in INS-1E cells. siRNA duplex designed to suppress
the expression of AKAP 18 a reduced AKAP 18 a and b expression
by 80%; in addition they also reduced AKAP 18 c and d expression
by around 30% (Fig. 2A). The reduction of all AKAP 18 transcripts
when this siRNA duplex was employed is not unexpected as there
is a high degree of sequence homology in the C-terminal end
among the four AKAP 18 isoforms [6]. At this level of AKAP 18
mRNA silencing, there was a signiﬁcant reduction of insulin secre-in AKAP 18 a – and AKAP 18 c – siRNA duplex-treated cells. Chemically synthesised
control siRNA duplex (grey), were transfected into INS-1E cells. After 48 h, the cells
) for 30 min. Silencing effects of AKAP 18 transcript mRNAs in siRNA-treated cells for
s. The insulin release in the corresponding (a/c) siRNA-treated cells are shown in (C)
P a/b and AKAP c/d are positive and negative mediators of insulin release. *P < 0.04,
Fig. 3. Glucose stimulates AKAP 18 a/b and suppresses AKAP 18 c/d mRNA levels.
INS-1E cells were cultured in RPMI 1640 for 24 h with 5.5, 16.7 and 22.2 mM
glucose. *P < 0.05, **P < 0.01, ***P < 0.001, ANOVA, six independent experiments
(means ± S.E.M.).
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(Fig. 2C). To verify the role of AKAP 18 a gene silencing in insulin
release, a second siRNA duplex designed to target the cds/exon 8
transition of the AKAP 18 mRNA (NM_001001801.3) also caused
a marked knockdown of AKAP18 a and a signiﬁcant decrease in
insulin secretion (P < 0.02) at 20 mM glucose (Supplementary ﬁg-
ure) in the presence of Fsk, which has no effect on AKAP 18 a
mRNA level (data not shown). Giving that AKAP 18 a is the pre-
dominant transcript variant expressed in beta cell, the impairmentFig. 4. Effect of palmitate and glucose on AKAP 18 a and c expression. INS-1E cells
(8  105 cells) were cultured in RPMI 1640. The day before the experiment, medium
was changed to RPMI 1640 containing 0.5% FCS. 24 h later, medium with 2.75 mg/
ml BSA and 5.5 or 11 mM glucose (G) with or without 250 lM palmitate (Pal) was
added to the cells for 24 h. Palmitate exposure resulted in decreased AKAP 18 a
mRNA expression at either glucose concentration (top). ***P < 0.001, ANOVA, three
separate experiments (means ± S.E.M.). Palmitate had no effect on AKAP 18 c
expression at either glucose concentrations, but glucose at 11 mM decreases AKAP
18 c mRNA.of insulin release related to the siRNA silencing of the AKAP 18
transcript variants observed here is likely attributed to the down
regulation of AKAP 18 a, although a minor role by the silencing
of AKAP 18 b cannot be ruled out. When AKAP c siRNA duplex
was used, there was a greater than 80% reduction of AKAP 18 c
and d mRNAs, and no effect on AKAP 18 a and b mRNA levels
(Fig. 2B) The siRNA-induced suppression of AKAP 18 c and d caused
an increased insulin (P < 0.04) release at 20 mM glucose in the
presence of Fsk (Fig. 2D).
3.3. Effects of glucose and palmitate on AKAP 18 a mRNA level
To assess the effect of glucose on the expression of AKAP 18
transcript variants in INS-1E cells, cells were cultivated in medium
containing 5.5, 16.7 or 22.2 mM glucose for 24 h. Glucose caused a
marked increase in AKAP 18 a/b expression (P < 0.05 and P < 0.01
at glucose 16.7 and 22.2 mM, respectively, for a, and P < 0.001 at
both glucose concentrations for b) and a signiﬁcant reduction in
AKAP 18 c/d mRNA expression (P < 0.001) (Fig. 3). In contrast, pal-
mitate caused a signiﬁcant reduction in AKAP 18 a expression
(P < 0.001) (Fig. 4, top). The effect was glucose-dependent with
40% and 73% inhibition in the presence of 5.5 and 11 mM glucose,
respectively, which is in line with previous data suggesting that
palmitate increases its deleterious effect on islet function at ele-
vated glucose levels [12]. There was no effect of palmitate on AKAP
18 c (Fig. 4, bottom). These data have extended the previous ﬁnd-
ings of palmitate and glucose on the expression of islet genes to in-
clude AKAP 18 transcript variants.
In pancreatic beta cells (bTC3 cells), the translocation of the PKA
catalytic subunits to either the plasma membrane (Cb) or the nu-
cleus (Ca) does not occur in the absence of glucose [13]. Together,Fig. 5. Growth hormone stimulates AKAP 18 a and suppresses AKAP 18 c
expression. INS-1E cells were cultured as in Fig. 4, except growth hormone (GH)
(0.5 lg/ml) was added on the day of the experiment for 24 h. GH treatment caused
a marked increase of AKAP 18 a mRNA levels, it attenuated the palmitate effect on
AKAP 18 a (top) and suppressed AKAP 18 c mRNA expression (bottom).
***P < 0.001, ANOVA, ﬁve separate experiments (means ± S.E.M.).
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PKA–AKAP interaction in beta cells.
3.4. Effects of growth hormone on the expression of AKAP 18 a and c
variants
GH treatment of INS-1E cells resulted in a marked increase in
AKAP 18 a mRNA at 11 mM glucose (Fig. 5, top) (P < 0.001) and
it reversed the palmitate-induced reduction of AKAP 18 a mRNA
expression (Fig. 5, top). In addition, we found that GH caused a
substantial decrease of the AKAP 18 c mRNA expression (Fig. 5,
bottom) (P < 0.001). GH promotes islets replication and palmitate
causes islets apoptosis [14,15]. The results suggest that GH and
palmitate are regulatory components of AKAP 18 a in glucose-
stimulated insulin secretion.
3.5. AKAP 18 isoform-speciﬁcity
The implications of AKAPs in islet biology have so far largely
been studied by peptide inhibitor(s) which disrupts PKA-AKAP
interaction [16,17] . This strategy would neither reveal the identity
of a particular AKAP nor its isoform(s) involved in biological action.
It is of note that recent data incorporating siRNA experimentation
have implicated AKAP 18 d in cardiac cellular activities [18,19];
AKAP 18 d has also previously been shown to affect renal function
[6], suggesting functional diversity among AKAP 18 isoforms.
AKAPs involved in glucose homeostasis are only beginning to
emerge [1,16,20] and further studies are required to investigate
other AKAPs which may affect islet functions. In conclusion, our
ﬁndings have demonstrated that AKAP 18 a is abundantly ex-
pressed in beta cells and that AKAP 18 isoform-speciﬁcity is in-
volved in regulating glucose-induced insulin secretion. The
opposing regulations by glucose on AKAP 18 a and c serve to en-
hance the cAMP-PKA signal-transduction in insulin secretion.
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